Mass Spectrometry Imaging

The mass analyzer records the mass-to-charge ratio associated with ions detected at each scanned position. These measurements provide chemical identity information that can be assigned to specific locations on the sample. Combining the recorded values with grid coordinates allows researchers to construct ion maps that show where particular compounds occur within tissue or biomaterial sections.

Preserving location connects a compound’s identity with its position in a tissue or biomaterial. This spatial relationship can reveal differences in composition across regions, show how engineered tissue is organized, and indicate where a drug or metabolic change occurs. The resulting information is more informative for biological interpretation than a compound list without spatial context.

Metabolic changes can be examined by mapping the chemical compounds present across defined areas of a biological sample. Researchers can determine whether altered molecular signals occur throughout a section or are concentrated in particular regions. In bioengineering studies, this supports analysis of disease models and helps relate metabolic patterns to tissue composition or engineered organization.

The workflow requires a surface that can be scanned across a defined grid, such as a tissue section or biomaterial section. Molecules must be ionized directly from positions on that surface so the measurements retain their coordinates. Selecting an appropriate section is therefore important for examining tissue composition, drug distribution, or biomaterial performance.

A typical workflow places the tissue or biomaterial section within a defined scanning grid, ionizes molecules directly at successive positions, and records mass-to-charge ratios with a mass analyzer. The positional measurements are then assembled into spatially resolved ion maps. These maps provide the basis for interpreting molecular composition and distribution across the analyzed surface.

Bioengineers can apply the method to characterize tissue composition, evaluate drug distribution, examine metabolic changes, and assess biomaterial performance. It is also useful for studying organization in engineered tissues. Because the measurements retain spatial information, the approach helps evaluate disease models, therapeutic delivery strategies, and regenerative strategies at the molecular level.

Ion maps show both the chemical signals detected and their locations within the sample. Researchers can use these spatial patterns to identify compounds associated with particular regions, tissue states, or engineered structures. This supports biomarker discovery by connecting candidate molecular signals with biological context rather than considering molecular measurements independently of the sample’s organization.